These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 11309125)

  • 1. Biological cost and compensatory evolution in fusidic acid-resistant Staphylococcus aureus.
    Nagaev I; Björkman J; Andersson DI; Hughes D
    Mol Microbiol; 2001 Apr; 40(2):433-9. PubMed ID: 11309125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Compensatory adaptation to the loss of biological fitness associated with acquisition of fusidic acid resistance in Staphylococcus aureus.
    Besier S; Ludwig A; Brade V; Wichelhaus TA
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1426-31. PubMed ID: 15793122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular analysis of fusidic acid resistance in Staphylococcus aureus.
    Besier S; Ludwig A; Brade V; Wichelhaus TA
    Mol Microbiol; 2003 Jan; 47(2):463-9. PubMed ID: 12519196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of elongation factor-G-mediated fusidic acid resistance and fitness compensation in Staphylococcus aureus.
    Koripella RK; Chen Y; Peisker K; Koh CS; Selmer M; Sanyal S
    J Biol Chem; 2012 Aug; 287(36):30257-67. PubMed ID: 22767604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic determinants of resistance to fusidic acid among clinical bacteremia isolates of Staphylococcus aureus.
    Lannergård J; Norström T; Hughes D
    Antimicrob Agents Chemother; 2009 May; 53(5):2059-65. PubMed ID: 19289529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A fusidic acid-resistant epidemic strain of Staphylococcus aureus carries the fusB determinant, whereas fusA mutations are prevalent in other resistant isolates.
    O'Neill AJ; Larsen AR; Henriksen AS; Chopra I
    Antimicrob Agents Chemother; 2004 Sep; 48(9):3594-7. PubMed ID: 15328136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of fusidic acid-resistant Staphylococcus aureus isolates in the community of Casablanca (Morocco).
    Elazhari M; Abu-Quatouseh LF; Elhabchi D; Zerouali K; Dersi N; Saile R; Timinouni M; Becker K
    Int J Med Microbiol; 2012 Mar; 302(2):96-100. PubMed ID: 22197537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure and function of FusB: an elongation factor G-binding fusidic acid resistance protein active in ribosomal translocation and recycling.
    Guo X; Peisker K; Bäckbro K; Chen Y; Koripella RK; Mandava CS; Sanyal S; Selmer M
    Open Biol; 2012 Mar; 2(3):120016. PubMed ID: 22645663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Staphylococcus aureus elongation factor G--structure and analysis of a target for fusidic acid.
    Chen Y; Koripella RK; Sanyal S; Selmer M
    FEBS J; 2010 Sep; 277(18):3789-803. PubMed ID: 20718859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increases in the mutation frequency at which fusidic acid-resistant Staphylococcus aureus arise with salicylate.
    Price CTD; Gustafson JE
    J Med Microbiol; 2001 Jan; 50(1):104-106. PubMed ID: 11192496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations in rpoB and fusA cause resistance to rifampicin and fusidic acid in methicillin-resistant Staphylococcus aureus strains from a tertiary hospital in Malaysia.
    Lim KT; Teh CS; Yusof MY; Thong KL
    Trans R Soc Trop Med Hyg; 2014 Feb; 108(2):112-8. PubMed ID: 24336696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance to fusidic acid.
    Turnidge J; Collignon P
    Int J Antimicrob Agents; 1999 Aug; 12 Suppl 2():S35-44. PubMed ID: 10528785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Occurrence and molecular characterization of fusidic acid resistance mechanisms among Staphylococcus spp. from European countries (2008).
    Castanheira M; Watters AA; Mendes RE; Farrell DJ; Jones RN
    J Antimicrob Chemother; 2010 Jul; 65(7):1353-8. PubMed ID: 20430787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of environment on compensatory mutations to ameliorate costs of antibiotic resistance.
    Björkman J; Nagaev I; Berg OG; Hughes D; Andersson DI
    Science; 2000 Feb; 287(5457):1479-82. PubMed ID: 10688795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic and phenotypic identification of fusidic acid-resistant mutants with the small-colony-variant phenotype in Staphylococcus aureus.
    Norström T; Lannergård J; Hughes D
    Antimicrob Agents Chemother; 2007 Dec; 51(12):4438-46. PubMed ID: 17923494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial activity and mechanisms of resistance to cephalosporin P1, an antibiotic related to fusidic acid.
    O'Neill AJ; Bostock JM; Moita AM; Chopra I
    J Antimicrob Chemother; 2002 Dec; 50(6):839-48. PubMed ID: 12461002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutation frequencies for resistance to fusidic acid and rifampicin in Staphylococcus aureus.
    O'Neill AJ; Cove JH; Chopra I
    J Antimicrob Chemother; 2001 May; 47(5):647-50. PubMed ID: 11328777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of global patterns and the genetics of fusidic acid resistance.
    Farrell DJ; Castanheira M; Chopra I
    Clin Infect Dis; 2011 Jun; 52 Suppl 7():S487-92. PubMed ID: 21546625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dissemination of fusidic acid resistance among Staphylococcus aureus clinical isolates.
    Yu F; Liu Y; Lu C; Lv J; Qi X; Ding Y; Li D; Huang X; Hu L; Wang L
    BMC Microbiol; 2015 Oct; 15():210. PubMed ID: 26463589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in fusA associated with posttherapy fusidic acid resistance in Clostridium difficile.
    Norén T; Akerlund T; Wullt M; Burman LG; Unemo M
    Antimicrob Agents Chemother; 2007 May; 51(5):1840-3. PubMed ID: 17307985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.